Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Non-Current Deferred Tax Liability came in at $17.1 million in Q1 2026, up 27.5% year-on-year from $13.4 million in Q1 2025, and up 11.0% on a QoQ basis from $15.4 million in Q4 2025.
Stevanato Group S.p.A (STVN) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $17.1 million in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 27.5% year-over-year to $17.1 million in Q1 2026; TTM through Mar 2026 was $17.1 million, a 27.5% increase from a year earlier, with the FY2025 full-year figure at $15.4 million, up 214.63% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $17.1 million, up from $15.4 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for STVN reached as high as $23.1 million in Q2 2023 and fell as low as -$21.4 million in Q4 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $11.0 million across 5 years, with a median of $14.6 million in 2025.
- Across the five-year window, Non-Current Deferred Tax Liability surged 233.43% in 2022 and plunged 53.27% in 2023, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at -$21.4 million in 2022, then jumped by 51.79% to -$10.3 million in 2023, then slumped by 30.35% to -$13.5 million in 2024, then surged by 214.63% to $15.4 million in 2025, then increased by 11.0% to $17.1 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $17.1 million in Q1 2026, $15.4 million in Q4 2025, and $15.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.13 Mn |
| Mar 31, 2026 | 17.13 Mn |
| Dec 31, 2025 | 15.43 Mn |
| Dec 31, 2025 | 15.43 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Sep 30, 2025 | 15.49 Mn |
| Jun 30, 2025 | 14.63 Mn |
| Jun 30, 2025 | 14.63 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Mar 31, 2025 | 13.44 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Dec 31, 2024 | -13.46 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Jun 30, 2024 | 11.38 Mn |
| Jun 30, 2024 | 11.38 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Dec 31, 2023 | -10.33 Mn |
| Dec 31, 2023 | -10.33 Mn |